Cargando…

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial

IMPORTANCE: Because transmission of ocular strains of Chlamydia trachomatis is greatest among preschool-aged children, limiting azithromycin distributions to this age group may conserve resources and result in less antimicrobial resistance, which is a potential advantage in areas with hypoendemic tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arzika, Ahmed M., Mindo-Panusis, Dallas, Abdou, Amza, Kadri, Boubacar, Nassirou, Beido, Maliki, Ramatou, Alsoudi, Amer F., Zhang, Tianyi, Cotter, Sun Y., Lebas, Elodie, O’Brien, Kieran S., Callahan, E. Kelly, Bailey, Robin L., West, Sheila K., Goodhew, E. Brook, Martin, Diana L., Arnold, Benjamin F., Porco, Travis C., Lietman, Thomas M., Keenan, Jeremy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399865/ https://www.ncbi.nlm.nih.gov/pubmed/35997979 http://dx.doi.org/10.1001/jamanetworkopen.2022.28244

Ejemplares similares

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger
por: Platts-Mills, James A, et al.
Publicado: (2022)

Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger
por: Hazel, Ashley, et al.
Publicado: (2023)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger
por: Kim, Jessica S., et al.
Publicado: (2019)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial
por: Arzika, Ahmed M., et al.
Publicado: (2021)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)

Monitoring transmission intensity of trachoma with serology
por: Tedijanto, Christine, et al.
Publicado: (2023)

Application of smartphone cameras for detecting clinically active trachoma
por: Bhosai, Satasuk Joy, et al.
Publicado: (2012)

Wastewater-Based Surveillance of Antimicrobial Resistance in Niger: An Exploratory Study
por: Ousmane, Sani, et al.
Publicado: (2023)

Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2018)

Comparison of door-to-door and fixed-point delivery of azithromycin distribution for child survival in Niger: A cluster-randomized trial
por: Arzika, Ahmed M., et al.
Publicado: (2023)

Mass Azithromycin and Malaria Parasitemia in Niger: Results from a Community-Randomized Trial
por: O'Brien, Kieran S., et al.
Publicado: (2017)

Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2020)

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2015)

Erratum to: Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
por: Liu, Fengchen, et al.
Publicado: (2016)

Community Risk Factors for Ocular Chlamydia Infection in Niger: Pre-Treatment Results from a Cluster-Randomized Trachoma Trial
por: Amza, Abdou, et al.
Publicado: (2012)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Reliability of Trachoma Clinical Grading—Assessing Grading of Marginal Cases
por: Rahman, Salman A., et al.
Publicado: (2014)

Does Mass Azithromycin Distribution Impact Child Growth and Nutrition in Niger? A Cluster-Randomized Trial
por: Amza, Abdou, et al.
Publicado: (2014)

Macrolide Resistance in MORDOR I: A Cluster-Randomized Trial in Niger
por: Doan, Thuy, et al.
Publicado: (2019)

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models
por: Liu, Fengchen, et al.
Publicado: (2015)

A Cluster-Randomized Controlled Trial Evaluating the Effects of Mass Azithromycin Treatment on Growth and Nutrition in Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Selection of Macrolide and Non-Macrolide Resistance with Mass Azithromycin Distribution: A Community-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2020)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
por: Lietman, Thomas M., et al.
Publicado: (2015)

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment
por: Kim, Matthew C., et al.
Publicado: (2019)

Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial
por: Arzika, Ahmed M, et al.
Publicado: (2021)

Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger
por: Phillips, Anna E., et al.
Publicado: (2020)

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Optimizing the Number of Child Deaths Averted with Mass Azithromycin Distribution
por: Oldenburg, Catherine E., et al.
Publicado: (2020)

Simplified dosing of oral azithromycin for children 1–11 months old in child survival programmes: age-based and height-based dosing protocols
por: Hu, Huiyu, et al.
Publicado: (2022)

Can we eradicate trachoma? A survey of stakeholders
por: Oldenburg, Catherine E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_93imhtlqm6be41fbjukdmskfe8